Constellation Pharmaceuticals Statistics Share Statistics Constellation Pharmaceuticals has 0
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding n/a Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) n/a Shares Floating n/a Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 1.41M, so 0% of the outstanding
shares have been sold short.
Short Interest 1.41M Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 2.04
Valuation Ratios The PE ratio is -10.87 and the forward
PE ratio is null.
Constellation Pharmaceuticals's PEG ratio is
0.85.
PE Ratio -10.87 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 3.34 P/FCF Ratio -12.22 PEG Ratio 0.85
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Constellation Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 14.03,
with a Debt / Equity ratio of 0.01.
Current Ratio 14.03 Quick Ratio 14.03 Debt / Equity 0.01 Debt / EBITDA -0.03 Debt / FCF -0.04 Interest Coverage -43.62
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-820.5K Employee Count 154 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax 39K Effective Tax Rate -0.03%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 2.58, so Constellation Pharmaceuticals's
price volatility has been higher than the market average.
Beta 2.58 52-Week Price Change n/a 50-Day Moving Average n/a 200-Day Moving Average n/a Relative Strength Index (RSI) n/a Average Volume (20 Days) 1,573,175
Income Statement
Revenue n/a Gross Profit n/a Operating Income -124.85M Net Income -126.36M EBITDA -122.81M EBIT -123.46M Earnings Per Share (EPS) -2.65
Full Income Statement Balance Sheet The company has 163.69M in cash and 4.23M in
debt, giving a net cash position of 159.47M.
Cash & Cash Equivalents 163.69M Total Debt 4.23M Net Cash 159.47M Retained Earnings -445.74M Total Assets n/a Working Capital n/a
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -111.42M
and capital expenditures -946K, giving a free cash flow of -112.37M.
Operating Cash Flow -111.42M Capital Expenditures -946K Free Cash Flow -112.37M FCF Per Share -2.36
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
